Pharmaceuticals & Drugs
THEMISMED
Themis Medicare Ltd.
Wait and Watch
Setup readiness
Early Trend
- Entry Zone
- ₹115.3-118.1
- Support Level
- ₹108.9
- Resistance
- ₹141.0
- Risk / Reward
- 2.5 : 1
- Risk Distance
- 7.8% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Developing setup
Some constructive elements are present, but leadership and breakout quality remain mixed.
Bullish factors
- MACD below zero — weak trend (−2).
- Moderate distance from 52w high (-31% below).
- Price remains distant from the pivot — breakout readiness is low.
- Relative strength remains below leadership thresholds.
- 1 prior pivot rejection in last 60d (-8 pts).
- 5 closes within 1.4% — tight band forming.
- BB squeeze — energy building.
- Pivot type: sloppy — lower follow-through expected.
- RSI 50 — ideal setup zone.
- Volume flow suggests quiet institutional accumulation.
Risk factors
- Thin liquidity (₹0.8 Cr/day) — slippage risk
- 4 distribution days recently — institutional selling
- Elevated failure risk (78/100)
Why not 100?
- RS rank is below elite leadership band (<90)
- Volume quality is not in top confirmation range yet
Overall view
The setup is still developing — leadership and trend alignment need further confirmation.
Trade management framework
Research framework only. Use your own risk controls.
- If price moves +1R, consider reducing downside by moving stop closer to entry.
- If price reaches around +1.5R to +2R, consider partial profit booking (for example 20-30%).
- If trend extends beyond +2R, consider trailing below a fast trend reference (for example 21 EMA).
Setup research
THEMISMED — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Why now
Building toward the pivot (13% below)
- Volume drying up into the base — supply fading
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Lagging (#20/30) — headwind
- Relative strength Lagging (RS 55)
- Trend strength Strong (ADX 31)
What invalidates it
This idea is wrong below ₹108.9 (-7.1% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹108.9
- Pivot — failure re-entry below₹117.5
Risk distance
Risk ≈ ₹9.16/share from entry ₹118.1.
Reasons to skip 3
Disqualifiers that apply even if the score looks good.
- Thin liquidity (₹0.8 Cr/day) — slippage risk
- 4 distribution days recently — institutional selling
- Elevated failure risk (78/100)
THEMISMED Support & Resistance Levels
Research chart
Daily price action with entry, stop, and target levels from our latest scan, plus relative strength vs Nifty.
Entry zone, stop and targets are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Trader brief
What to understand
THEMISMED Entry, Stop-Loss & Targets
Research heuristic · not a buy/sell call
Low scanner score suggests weak or incomplete structure. Use this page for context, not as a primary trade candidate until the score and trend improve.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Setup highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Setup metrics Weak
THEMISMED Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Structure
Momentum
Risk
More scanner fields
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
THEMISMED FAQ Common swing-trading questions
Frequently asked questions about THEMISMED
Is THEMISMED a good swing trade right now?
On Swing Edge's swing-setup framework, Themis Medicare Ltd. (THEMISMED) currently grades C — mixed — needs patience. Building toward the pivot (13% below). Flagged today. This is educational research, not investment advice.
What are THEMISMED's support and resistance levels?
For THEMISMED, near-term support sits around ₹108.9 (the base/stop zone); overhead resistance is around ₹117.5 (the breakout pivot); the next resistance above is ₹141.0. This is educational research, not investment advice.
What is the breakout / pivot level for THEMISMED?
The breakout pivot for THEMISMED is around ₹117.5. Price is about 13.4% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is THEMISMED above its 50-day and 200-day moving averages?
Yes — THEMISMED is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is THEMISMED versus the market (RS rank)?
THEMISMED has a relative strength (RS) rank of 55 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 31, indicating a strong trend. This is educational research, not investment advice.
What are the entry, stop-loss and target levels for THEMISMED?
Reference swing levels for THEMISMED: entry around ₹118.1, stop-loss around ₹108.9, targets at ₹141.0 and ₹178.8. That works out to roughly a 2.5:1 reward-to-risk on the first target. These are reference levels for study only — this is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-19 — not live intraday NSE quotes.